{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:47:33Z","timestamp":1790754453215,"version":"4.1.0"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.2146\/ajhp160961","type":"journal-article","created":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T01:45:47Z","timestamp":1515203147000},"page":"97-104","source":"Crossref","is-referenced-by-count":82,"title":["Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency"],"prefix":"10.1093","volume":"75","author":[{"given":"Kristen D.","family":"Belfield","sequence":"first","affiliation":[{"name":"Yale New Haven Hospital, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Tichy","sequence":"additional","affiliation":[{"name":"Yale New Haven Hospital, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041105233038600_b1-0750097","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.blre.2007.05.002","article-title":"G6PD deficiency: the genotype-phenotype association","volume":"21","author":"Mason","year":"2007","journal-title":"Blood Rev"},{"key":"key\n\t\t\t\t2019041105233038600_b2-0750097","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"371","author":"Cappellini","year":"2008","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041105233038600_b3-0750097","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bcmd.2008.12.005","article-title":"The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis","volume":"42","author":"Nkhoma","year":"2009","journal-title":"Blood Cells Mol Dis"},{"key":"key\n\t\t\t\t2019041105233038600_b4-0750097","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM197905033001801","article-title":"Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients","volume":"300","author":"Heller","year":"1979","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041105233038600_b5-0750097","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.124.3220.484-a","article-title":"Enzymatic deficiency in primaquine-sensitive erythrocytes","volume":"124","author":"Carson","year":"1956","journal-title":"Science"},{"key":"key\n\t\t\t\t2019041105233038600_b6-0750097","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1475-2875-13-418","article-title":"Primaquine: the risks and the benefits","volume":"13","author":"Ashley","year":"2014","journal-title":"Malar J"},{"key":"key\n\t\t\t\t2019041105233038600_b7-0750097","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1182\/blood.V84.11.3613.bloodjournal84113613","article-title":"G6PD deficiency","volume":"84","author":"Beutler","year":"1994","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019041105233038600_b8-0750097","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.hoc.2015.11.006","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"30","author":"Luzzatto","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"key":"key\n\t\t\t\t2019041105233038600_b9-0750097","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bjh.12665","article-title":"G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications","volume":"164","author":"Luzzatto","year":"2014","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t2019041105233038600_b10-0750097","first-page":"601","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"67","author":"WHO Working Group","year":"1989","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t2019041105233038600_b11-0750097","first-page":"440","article-title":"Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) variants in Italy","volume":"82","author":"Martinez di Montemuros","year":"1997","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t2019041105233038600_b12-0750097","article-title":"A guide to fluorescent spot testing for G6PD deficiency","author":"PATH","year":"2014"},{"key":"key\n\t\t\t\t2019041105233038600_b13-0750097","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12916-015-0531-0","article-title":"Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency","volume":"13","author":"Baird","year":"2015","journal-title":"BMC Med"},{"key":"key\n\t\t\t\t2019041105233038600_b14-0750097","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/iub.137","article-title":"Glucose-6-phosphate dehydrogenase laboratory assay: how, when, and why?","volume":"61","author":"Minucci","year":"2009","journal-title":"IUBMB Life"},{"key":"key\n\t\t\t\t2019041105233038600_b15-0750097","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-3156.2003.01055.x","article-title":"An improved, simple screening method for detection of glucose-6-phosphate dehydrogenase deficiency","volume":"8","author":"Tantular","year":"2003","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t2019041105233038600_b16-0750097","doi-asserted-by":"crossref","first-page":"e0148172","DOI":"10.1371\/journal.pone.0148172","article-title":"Comparison of three screening test kits for G6PD enzyme deficiency: implications for its use in the radical cure of vivax malaria in remote and resource-poor areas in the Philippines","volume":"11","author":"Espino","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041105233038600_b17-0750097","doi-asserted-by":"crossref","first-page":"e28357","DOI":"10.1371\/journal.pone.0028357","article-title":"Performance of the CareStart G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041105233038600_b18-0750097","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4269\/ajtmh.14-0298","article-title":"Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects","volume":"92","author":"Osorio","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t2019041105233038600_b19-0750097","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4269\/ajtmh.2010.09-0416","article-title":"Evaluation of a rapid qualitative enzyme chromatographic test for glucose-6-phosphate dehydrogenase deficiency","volume":"82","author":"Tinley","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t2019041105233038600_b20-0750097","doi-asserted-by":"crossref","first-page":"e0125796","DOI":"10.1371\/journal.pone.0125796","article-title":"Evaluation of the diagnostic accuracy of CareStart G6PD deficiency rapid diagnostic test (RDT) in a malaria endemic area in Ghana, Africa","volume":"10","author":"Adu-Gyasi","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041105233038600_b21-0750097","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12936-015-0896-8","article-title":"The challenges of introducing routine G6PD testing into radical cure: a workshop report","volume":"14","author":"Ley","year":"2015","journal-title":"Malar J"},{"key":"key\n\t\t\t\t2019041105233038600_b22-0750097","doi-asserted-by":"crossref","first-page":"e1268","DOI":"10.1542\/peds.2015-2122","article-title":"Point-of-care quantitative measure of glucose-6-phosphate dehydrogenase enzyme deficiency","volume":"136","author":"Bhutani","year":"2015","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t2019041105233038600_b23-0750097","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.cca.2012.01.032","article-title":"Rapid and simple identification of the commonest glucose-6-phosphate dehydrogenase (G6PD) Italian mutations: from DNA extraction to genotyping","volume":"413","author":"Minucci","year":"2012","journal-title":"Clin Chim Acta"},{"key":"key\n\t\t\t\t2019041105233038600_b24-0750097","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bcmd.2012.01.001","article-title":"Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the \u201cold\u201d and update of the new mutations","volume":"48","author":"Minucci","year":"2012","journal-title":"Blood Cells Mol Dis"},{"key":"key\n\t\t\t\t2019041105233038600_b25-0750097","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0022-3476(72)80024-6","article-title":"G-6-PD hemolytic anemia complicating diabetic ketoacidosis","volume":"80","author":"Gellady","year":"1972","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019041105233038600_b26-0750097","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/bmj.288.6412.179","article-title":"Diabetic ketoacidosis does not precipitate haemolysis in patients with the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency","volume":"288","author":"Shalev","year":"1984","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041105233038600_b27-0750097","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1089-3261(02)00050-8","article-title":"Anemia and the liver: hepatobiliary manifestations of anemia","volume":"6","author":"Edwards","year":"2002","journal-title":"Clin Liver Dis"},{"key":"key\n\t\t\t\t2019041105233038600_b28-0750097","first-page":"1277","article-title":"Diagnosis and management of G6PD deficiency","volume":"72","author":"Frank","year":"2005","journal-title":"Am Fam Physician"},{"key":"key\n\t\t\t\t2019041105233038600_b29-0750097","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0140-6736(66)90098-5","article-title":"Viral hepatitis in G.-6.-P.D. deficiency","volume":"1","author":"Choremis","year":"1966","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041105233038600_b30-0750097","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0140-6736(73)91602-4","article-title":"Glucose-6-phosphate-dehydrogenase deficiency in Nigerians with jaundice associated with lobar pneumonia","volume":"1","author":"Tugwell","year":"1973","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041105233038600_b31-0750097","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/milmed\/163.6.434","article-title":"Hepatitis A and cytomegalovirus infection precipitating acute hemolysis in glucose-6-phosphate dehydrogenase deficiency","volume":"163","author":"Siddiqui","year":"1998","journal-title":"Mil Med"},{"key":"key\n\t\t\t\t2019041105233038600_b32-0750097","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0009-9120(79)80078-8","article-title":"An examination of the role of vitamin E in glucose-6-phosphate dehydrogenase deficiency","volume":"12","author":"Newman","year":"1979","journal-title":"Clin Biochem"},{"key":"key\n\t\t\t\t2019041105233038600_b33-0750097","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7326\/0003-4819-90-1-53","article-title":"Improved erythrocyte survival with high-dose vitamin E in chronic hemolyzing G6PD and glutathione synthetase deficiencies","volume":"90","author":"Spielberg","year":"1979","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041105233038600_b34-0750097","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJM198304283081708","article-title":"High-dose vitamin E does not decrease the rate of chronic hemolysis in glucose-6-phosphate dehydrogenase deficiency","volume":"308","author":"Johnson","year":"1983","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041105233038600_b35-0750097","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0140-6736(72)91724-2","article-title":"Reversible renal failure and G6PD deficiency","volume":"2","author":"Selroos","year":"1972","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041105233038600_b36-0750097","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0140-6736(72)91619-4","article-title":"Glucose-6-phosphate dehydrogenase deficiency and acute renal failure","volume":"2","author":"Angle","year":"1972","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041105233038600_b37-0750097","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/11536520-000000000-00000","article-title":"Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review","volume":"33","author":"Youngster","year":"2010","journal-title":"Drug Saf"},{"key":"key\n\t\t\t\t2019041105233038600_b38-0750097","article-title":"Primaquine phosphate prescribing information","author":"Sanofi-Synthelabo Inc"},{"issue":"suppl","key":"key\n\t\t\t\t2019041105233038600_b39-0750097","first-page":"165","article-title":"The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency","volume":"35","author":"Degowin","year":"1966","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t2019041105233038600_b40-0750097","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1182\/blood-2012-03-416032","article-title":"Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone","volume":"120","author":"Pamba","year":"2012","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019041105233038600_b41-0750097","doi-asserted-by":"crossref","first-page":"e17371","DOI":"10.1371\/journal.pone.0017371","article-title":"Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia","volume":"6","author":"Dunyo","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041105233038600_b42-0750097","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40064-015-0816-y","article-title":"Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literature","volume":"4","author":"Lee","year":"2015","journal-title":"Springerplus"},{"key":"key\n\t\t\t\t2019041105233038600_b43-0750097","volume-title":"Dapsone package insert","year":"2009"},{"key":"key\n\t\t\t\t2019041105233038600_b44-0750097","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/clpt.2014.97","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype","volume":"96","author":"Relling","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041105233038600_b45-0750097","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ccr3.495","article-title":"Rasburicase-induced methemoglobinemia: case report, literature review, and proposed treatment algorithm","volume":"4","author":"Sherwood","year":"2016","journal-title":"Clin Case Rep"},{"key":"key\n\t\t\t\t2019041105233038600_b46-0750097","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1177\/1060028013501996","article-title":"Mortality following rasburicase-induced methemoglobinemia","volume":"47","author":"Bucklin","year":"2013","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041105233038600_b47-0750097","volume-title":"sanofi-aventis U.S. LLC. Elitek (rasburicase) prescribing information"},{"key":"key\n\t\t\t\t2019041105233038600_b48-0750097","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.2146\/ajhp150591","article-title":"I.V. ascorbic acid for treatment of apparent rasburicase-induced methemoglobinemia in a patient with acute kidney injury and assumed glucose-6-phosphate dehydrogenase deficiency","volume":"73","author":"Reeves","year":"2016","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019041105233038600_b49-0750097","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ajh.23182","article-title":"Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase","volume":"88","author":"Sonbol","year":"2013","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t2019041105233038600_b50-0750097","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MJT.0000000000000028","article-title":"Ascorbic acid for the treatment of methemoglobinemia: the experience of a large tertiary care pediatric hospital","volume":"21","author":"Rino","year":"2014","journal-title":"Am J Ther"},{"key":"key\n\t\t\t\t2019041105233038600_b51-0750097","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.tjem.2014.09.002","article-title":"Methemoglobinemia caused by dapsone overdose: which treatment is best?","volume":"15","author":"Toker","year":"2015","journal-title":"Turk J Emerg Med"},{"key":"key\n\t\t\t\t2019041105233038600_b52-0750097","doi-asserted-by":"crossref","first-page":"684.e1","DOI":"10.1016\/j.ajem.2013.11.036","article-title":"High-dose vitamin C management in dapsone-induced methemoglobinemia","volume":"32","author":"Park","year":"2014","journal-title":"Am J Emerg Med"},{"key":"key\n\t\t\t\t2019041105233038600_b53-0750097","doi-asserted-by":"crossref","first-page":"e12718","DOI":"10.5812\/ircmj.12718","article-title":"Toxic methemoglobinemia treated with ascorbic acid: case report","volume":"15","author":"Topal","year":"2013","journal-title":"Iran Red Crescent Med J"},{"key":"key\n\t\t\t\t2019041105233038600_b54-0750097","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1177\/106002809002401213","article-title":"Hemolytic reactions to nitrofurantoin in patients with glucose-6-phosphate dehydrogenase deficiency: theory and practice","volume":"24","author":"Gait","year":"1990","journal-title":"DICP"},{"key":"key\n\t\t\t\t2019041105233038600_b55-0750097","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1177\/106002808702101116","article-title":"Phenazopyridine-induced hemolytic anemia in G-6-PD deficiency","volume":"21","author":"Galun","year":"1987","journal-title":"Drug Intell Clin Pharm"},{"key":"key\n\t\t\t\t2019041105233038600_b56-0750097","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000206727","article-title":"Phenazopyridine-induced hemolytic anemia in a patient with G6PD deficiency","volume":"70","author":"Tishler","year":"1983","journal-title":"Acta Haematol"},{"key":"key\n\t\t\t\t2019041105233038600_b57-0750097","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0140-6736(82)90651-1","article-title":"Acute hemolytic anaemia due to phenazopyridine hydrochloride in G-6-PD deficient subject","volume":"2","author":"Mercieca","year":"1982","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041105233038600_b58-0750097","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00007611-198903000-00023","article-title":"Methemoglobinemia and hemolytic anemia after phenazopyridine hydrochloride (Pyridium) administration in end-stage renal disease","volume":"82","author":"Fincher","year":"1989","journal-title":"South Med J"},{"key":"key\n\t\t\t\t2019041105233038600_b59-0750097","first-page":"280","article-title":"Phenazopyridine (Pyridium) poisoning: possible toxicity of methylene blue administration in renal failure","volume":"53","author":"Sharon","year":"1986","journal-title":"Mt Sinai J Med"},{"key":"key\n\t\t\t\t2019041105233038600_b60-0750097","article-title":"Macrobid (nitrofurantoin) prescribing information","author":"Norwich Pharmaceuticals, Inc"},{"key":"key\n\t\t\t\t2019041105233038600_b61-0750097","volume-title":"Phenazopyridine hydrochloride package insert","year":"2011"},{"key":"key\n\t\t\t\t2019041105233038600_b62-0750097","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/RHU.0000000000000370","article-title":"Hemolytic anemia induced by pegloticase infusion in a patient with G6PD deficiency","volume":"22","author":"Owens","year":"2016","journal-title":"J Clin Rheumatol"},{"key":"key\n\t\t\t\t2019041105233038600_b63-0750097","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1093\/rheumatology\/keu346","article-title":"Methaemoglobinaemia and haemolysis following pegloticase infusion for refractory gout in a patient with a falsely negative glucose-6-phosphate dehydrogenase deficiency result","volume":"53","author":"Geraldino-Pardilla","year":"2014","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t2019041105233038600_b64-0750097","article-title":"Krystexxa (pegloticase) prescribing information","author":"Savient Pharmaceuticals, Inc"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/75\/3\/97\/28346892\/ajhp0097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T08:20:55Z","timestamp":1603614055000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/75\/3\/97\/5102042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp160961","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2,1]]},"published":{"date-parts":[[2018,2,1]]}}}